About The ASCO Post
The ASCO Post is a Healthcare company. Publishing of oncology news and cancer research updates. The ASCO Post offers products and services including Oncology News Services and Medical Guidelines Updates. Its focus areas include Medical Publishing, Oncology News, Cancer Research Services and Education. Its legal entity is HSP News Service, L.L.C.
Company details
Information on cancer research, treatments, and patient engagement is provided by The ASCO Post, a publication focused on oncology topics such as lung cancer risks and breast cancer survivorship. Studies on conditions like interstitial lung disease and type 2 diabetes in relation to cancer are discussed, emphasizing the need for inclusion in clinical research. Updates to guidelines for non-small cell lung cancer are included, drawing from various studies and meetings. Advances in patient-centered approaches and cancer subtypes are highlighted to support informed practices in the field.
- SectorsHealthcare
- Email••••••••
- Legal Name Hsp News Service, L.L.C.
Products & Services of The ASCO Post
The ASCO Post offers a comprehensive portfolio of products and services, including Oncology News Services and Medical Guidelines Updates.
News and updates on cancer research and treatments are provided through articles and publications.
Guidelines and living updates for cancer treatments are disseminated based on study findings.
Web traffic of The ASCO Post
Websites that share an audience with The ASCO Post (ascopost.com).
Websites whose visitors overlap most with The ASCO Post. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| healthmatch.io | 92% | 1.3M | #24,284 | View details | |
| genomeweb.com | 89% | 116.4K | #371,609 | View details | |
| eortc.org | 84% | 92.1K | #366,289 | View details | |
| foxchase.org | 83% | 111.1K | #341,787 | View details | |
| curetoday.com | 80% | 114.9K | #378,005 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for The ASCO Post
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about The ASCO Post
Information on cancer research, treatments, and patient engagement is provided by The ASCO Post, a publication focused on oncology topics such as lung cancer risks and breast cancer survivorship. Studies on conditions like interstitial lung disease and type 2 diabetes in relation to cancer are discussed, emphasizing the need for inclusion in clinical research. Updates to guidelines for non-small cell lung cancer are included, drawing from various studies and meetings. Advances in patient-centered approaches and cancer subtypes are highlighted to support informed practices in the field.
The ASCO Post offers Oncology News Services and Medical Guidelines Updates.
The ASCO Post operates through Hsp News Service, L.L.C..